Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Apr;7(Suppl 2):S153-S157.
doi: 10.21037/tlcr.2018.03.18.

Durvalumab for non-resectable stage IIIB non-small cell lung cancer-a small step or a big leap?

Wolfram C M Dempke  1   2 , Klaus Fenchel  3
Affiliations
Editorial

Durvalumab for non-resectable stage IIIB non-small cell lung cancer-a small step or a big leap?

Wolfram C M Dempke et al. Transl Lung Cancer Res. 2018 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

  • Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
    Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeño J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Özgüroğlu M; PACIFIC Investigators. Antonia SJ, et al. N Engl J Med. 2017 Nov 16;377(20):1919-1929. doi: 10.1056/NEJMoa1709937. Epub 2017 Sep 8. N Engl J Med. 2017. PMID: 28885881 Clinical Trial.

References

    1. Jones CM, Brunelli A, Callister ME, et al. Multimodality treatment of advanced non-small cell lung cancer: where are we with evidence? Curr Surg Rep 2018;6:5. 10.1007/s40137-018-0202-0 - DOI - PMC - PubMed
    1. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 1987;59:1874-81. 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z - DOI - PubMed
    1. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small-cell lung cancer: 7-year follow-up of cancer and leukaemia group B (CALGB) 8433 trial. J Natl Cancer Inst 1996;88:1210-5. 10.1093/jnci/88.17.1210 - DOI - PubMed
    1. Auperin A, Le Pechoux C, Rolland E, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181-90. 10.1200/JCO.2009.26.2543 - DOI - PubMed
    1. Reymen B, van Baardwijk A, Wanders R, et al. Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemoradiotherapy using individualised isotoxic accelareted radiotherapy (INDAR). Radiother Oncol 2014;110:482-7. 10.1016/j.radonc.2013.12.005 - DOI - PubMed

LinkOut - more resources